ADDPI 2023_132 INADA vs Khushi

In May 2023 the India National Anti-Doping Agency (INADA) reported an anti-doping rule violation against the powerlifter Khushi after her sample tested positive for the prohibited substances Clenbuterol, Mephentermine and Methasterone.

Following notification a provisional suspension was ordered and she was heard for the Anti-Doping Disciplinary Panel of India (ADDPI).

The Panel finds that the presence of prohibited substances has been established in the Athlete's sample and accordingly that she committed an anti-doping rule violation.

Therefore the Panel decides on 16 October 2023 to impose a 4 year period of ineligibility on the Athlete, starting on the date of the provisional suspension, i.e. on 8 May 2023.

Original document

Parameters

Legal Source
National Decisions
Date
16 October 2023
Arbitrator
Kumar, Akhil
Soodan, Sanjogita
Zongluju, Jyoti
Original Source
India National Anti-Doping Agency (INADA)
Country
India
Language
English
ADRV
Adverse Analytical Finding / presence
Sport/IFs
Powerlifting (IPF) - International Powerlifting Federation
Other organisations
Anti-Doping Disciplinary Panel of India (ADDPI)
India National Anti-Doping Agency (INADA)
Laboratories
New Delhi, India: National Dope Testing Laboratory
Doping classes
S1. Anabolic Agents
S6. Stimulants
Substances
Clenbuterol
Mephentermine
Methasterone (17β-hydroxy-2α,17α-dimethyl-5α-androstan-3-one)
Document type
Pdf file
Date generated
14 November 2023
Date of last modification
7 December 2023
Category
  • Legal Source
  • Education
  • Science
  • Statistics
  • History
Country & language
  • Country
  • Language
Other filters
  • ADRV
  • Legal Terms
  • Sport/IFs
  • Other organisations
  • Laboratories
  • Analytical aspects
  • Doping classes
  • Substances
  • Medical terms
  • Various
  • Version
  • Document category
  • Document type
Publication period
Origin